Feifei Chu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Distinct Gut Microbiome and Metabolome Profiles Associate with Differential Responses to Immunotherapy in Colorectal Cancer.
Journal: Polish journal of microbiology
Published: December 25, 2025
Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study.
Journal: Medicine
Published: October 09, 2025
Macrophage USP9X attenuates colitis by restricting oncostatin M production via K27-linked deubiquitination of STAT1.
Journal: Cellular & molecular immunology
Published: August 25, 2025
Efficacy of different administration methods of vonoprazan for gastroesophageal reflux disease: a retrospective cohort study.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: August 07, 2025
RNF2 mediates H2A ubiquitination to promote colitis via suppressing monocyte-macrophage transition in mice.
Journal: Nature communications
Published: June 26, 2025
Downregulation of circ-RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3).
Journal: Environmental toxicology
Published: December 08, 2023
Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer.
Journal: Cancer science
Published: October 25, 2023
Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer.
Journal: Pathology oncology research : POR
Published: April 21, 2022
Last Updated: 09/26/2026